Equities

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.9238
  • Today's Change0.019 / 2.05%
  • Shares traded578.10k
  • 1 Year change-16.02%
  • Beta1.2778
Data delayed at least 15 minutes, as of Nov 09 2024 01:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Saturday, Lineage Cell Therapeutics Inc (LCTX:ASQ) closed at 0.9238, 20.52% above the 52 week low of 0.7665 set on Aug 14, 2024.
52-week range
Today
0.7665Aug 14 20241.61Mar 28 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.89
High0.9449
Low0.88
Bid0.91
Offer0.9399
Previous close0.9052
Average volume456.53k
Shares outstanding188.84m
Free float188.00m
P/E (TTM)--
Market cap174.45m USD
EPS (TTM)-0.1342
USD
Data delayed at least 15 minutes, as of Nov 09 2024 01:00 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.